Opening book details…
Can I read Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) on EtoBox?
Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) by Neil J. Clendeninn, Krzysztof Appelt is a nonfiction available to read on EtoBox.
What is Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) about?
Cutting-edge investigators review the current status of the entire field, from the biology of MMPs through the current clinical studies. The authors include many leading scientists from pharmaceutical companies who present all the latest concepts and results on the preferred design strategies for MMP inhibitors, their molecular mechanisms, and their substrates. In addition, they fully describe their personal research on specific MMP inhibitors, detailing vanguard design strategies, their in vitro activity, the outcome of animal model studies and, where available, their toxicology, safety, efficacy in human clinical trials. Comprehensive and state-of-the-art, Matrix Metalloproteinase Inhibitors in Cancer Therapy offers basic and clinical investigators alike a richly informative summary of all the latest research on these powerful new drugs, and their high promise as emerging cancer therapeutics.
Who reads Matrix Metalloproteinase Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Neil J. Clendeninn, Krzysztof Appelt
- Publisher
- Humana Press Imprint : Humana Press
- Published
- 2001
- Language
- EN
- ISBN
- 9781617371233
- Category
- nonfiction
- Subjects
- Medical, Science, Chemistry
Other editions & translations
More by Neil J. Clendeninn, Krzysztof Appelt
Browse all works by Neil J. Clendeninn, Krzysztof Appelt
Similar books
- STAT Inhibitors in Cancer (Cancer Drug Discovery and Development) — Alister C. Ward (2016)
- DNA Repair in Cancer Therapy (Cancer Drug Discovery and Development) — Brian Leyland-Jones MD (auth.), Lawrence C. Panasci MD, Moulay A. Alaoui-Jamali DVM, PhD (2004)
- Camptothecins in Cancer Therapy (Cancer Drug Discovery and Development) — Leroy F. Liu PhD, Shyamal D. Desai PhD (auth.), Val R. Adams PharmD, Thomas G. Burke (2005)
- COX-2 Blockade in Cancer Prevention and Therapy (Cancer Drug Discovery and Development) (Cancer Drug Discovery and Development) — Rashida A. Karmali JD PhD (auth.), Randall E. Harris MD, (2003)
- Regional Cancer Therapy (Cancer Drug Discovery and Development) — Ulrike S. Stein PhD, Wolfgang Walther PhD, Peter M. Schlag MD, PhD (auth.), Peter M. Schlag MD, Ulrike Stein PhD, Alexander M. Eggermont (2007)
- Deoxynucleoside Analogs in Cancer Therapy (Cancer Drug Discovery and Development) — Marçal Pastor-Anglada MSc, PhD (auth.), Godefridus J. Peters (2006)
